Blog
RSS FeedPosted by Michael Wonder on 06 Apr 2020
Read about a new COVID-19 treatment study? It probably won't work.
6 April 2020 - Most new drugs that show promise as potential COVID-19 cures will not end up working, scientists ...
Posted by Michael Wonder on 06 Apr 2020
COVID-19: CSL joins global hunt for vaccine
6 April 2020 - Biotechnology company CSL has weighed into the global race to fight the coronavirus by partnering with ...
Posted by Michael Wonder on 03 Apr 2020
International regulators discuss available knowledge supporting COVID-19 medicine development
3 April 2020 - On 2 April, regulators from around the world joined the second workshop on COVID-19 organised by ...
Posted by Michael Wonder on 02 Apr 2020
CSIRO scientists in Australia start testing potential coronavirus vaccine on ferrets
2 April 2020 - Ferrets have been injected with two trial vaccines for coronavirus at CSIRO’s Geelong animal testing laboratory to ...
Posted by Michael Wonder on 02 Apr 2020
COVID-19 has changed how the world does science, together
1 April 2020 - Never before, scientists say, have so many of the world’s researchers focused so urgently on a single ...
Posted by Michael Wonder on 01 Apr 2020
Coronavirus Treatment Acceleration Program
1 April 2020 - FDA has created a special emergency program for possible therapies, the Coronavirus Treatment Acceleration Program. ...
Posted by Michael Wonder on 01 Apr 2020
COVID-19 update: FDA continues to accelerate development of novel therapies for COVID-19
31 March 2020 - As part of the Trump Administration’s all-hands-on-deck approach across public, academic and private sectors to combat the ...
Posted by Michael Wonder on 31 Mar 2020
Advancing regulatory science in the EU – new strategy adopted
31 March 2020 - EMA has published its Regulatory Science Strategy to 2025 today. ...
Posted by Michael Wonder on 31 Mar 2020
Developing COVID-19 vaccines at pandemic speed
30 March 2020 - Rapid publication of a perspective co-authored by former head of Australian Department of Health. ...
Posted by Michael Wonder on 31 Mar 2020
Clinical trial processes
31 March 2020 - The TGA has received a number of enquiries about processes for clinical trials relating to COVID-19 ...
Posted by Michael Wonder on 30 Mar 2020
Johnson & Johnson announces a lead vaccine candidate for COVID-19; landmark new partnership with U.S. Department of Health & Human Services; and commitment to supply one billion vaccines worldwide for emergency pandemic use
30 March 2020 - Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020. ...
Posted by Michael Wonder on 26 Mar 2020
Crowdsourcing to fight COVID-19
26 March 2020 - “We are trying to fly the plane while we are building it.” ...
Posted by Michael Wonder on 26 Mar 2020
FDA continues to support transparency and collaboration in drug approval process as the clinical data summary pilot concludes
26 March 2020 - As our society becomes more global, it has become increasingly clear that the U.S. FDA needs to ...
Posted by Michael Wonder on 26 Mar 2020
Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
26 March 2020 - Collaboration to address product development and scale up challenges posed by current pandemic. ...
Posted by Michael Wonder on 24 Mar 2020
Global regulators map out data requirements for phase 1 COVID-19 vaccine trials
24 March 2020 - Global regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine ...